APO Research
Talk to an analyst

APO RESEARCH · REPORT

Edaravone

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Edaravone Market Analysis and Forecast 2026-2032

26 December 2025190 pages

Choose your research edition.

Industry ResearchEdaravone Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Edaravone Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Edaravone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Edaravone Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Edaravone Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Edaravone market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Edaravone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Edaravone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Edaravone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Edaravone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Edaravone include Mitsubishi Tanabe Pharma, Piramal Healthcare, Simcere, Sun Pharmaceutical Industries Ltd., Taj Pharmaceuticals Ltd., UCB India Ltd and Unichem Laboratories Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Edaravone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Edaravone, also provides the sales of main regions and countries. Of the upcoming market potential for Edaravone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Edaravone sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Edaravone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Edaravone sales, projected growth trends, production technology, application and end-user industry.

Edaravone Segment by Company

Mitsubishi Tanabe Pharma

Piramal Healthcare

Simcere

Sun Pharmaceutical Industries Ltd.

Taj Pharmaceuticals Ltd.

UCB India Ltd

Unichem Laboratories Ltd

Edaravone Segment by Type

Oral Edaravone

Injection Edaravone

Edaravone Segment by Application

Hospital

Clinic

Others

Edaravone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Edaravone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Edaravone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Edaravone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Edaravone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Edaravone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Edaravone sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Edaravone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Edaravone Major Manufacturers Table 3. Injection Edaravone Major Manufacturers Table 4. Global Edaravone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Others Major Manufacturers Table 8. Edaravone Industry Trends Table 9. Edaravone Industry Drivers Table 10. Edaravone Industry Opportunities and Challenges Table 11. Edaravone Industry Restraints Table 12. Global Edaravone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Edaravone Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Edaravone Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Edaravone Revenue Market Share by Region (2021-2026) Table 16. Global Edaravone Revenue Market Share by Region (2027-2032) Table 17. Global Edaravone Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Edaravone Sales by Region (2021-2026) & (K Units) Table 19. Global Edaravone Sales by Region (2027-2032) & (K Units) Table 20. Global Edaravone Sales Market Share by Region (2021-2026) Table 21. Global Edaravone Sales Market Share by Region (2027-2032) Table 22. Global Edaravone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Edaravone Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Edaravone Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Edaravone Sales Market Share by Manufacturers (2021-2026) Table 26. Global Edaravone Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Edaravone Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Edaravone Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Edaravone Manufacturers, Product Type & Application Table 30. Global Edaravone Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Edaravone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Edaravone Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Edaravone Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Edaravone Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Edaravone Revenue Market Share by Type (2021-2026) Table 37. Global Edaravone Revenue Market Share by Type (2027-2032) Table 38. Global Edaravone Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Edaravone Sales by Type (2021-2026) & (K Units) Table 40. Global Edaravone Sales by Type (2027-2032) & (K Units) Table 41. Global Edaravone Sales Market Share by Type (2021-2026) Table 42. Global Edaravone Sales Market Share by Type (2027-2032) Table 43. Global Edaravone Price by Type (2021-2026) & (US$/Unit) Table 44. Global Edaravone Price by Type (2027-2032) & (US$/Unit) Table 45. Global Edaravone Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Edaravone Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Edaravone Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Edaravone Revenue Market Share by Application (2021-2026) Table 49. Global Edaravone Revenue Market Share by Application (2027-2032) Table 50. Global Edaravone Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Edaravone Sales by Application (2021-2026) & (K Units) Table 52. Global Edaravone Sales by Application (2027-2032) & (K Units) Table 53. Global Edaravone Sales Market Share by Application (2021-2026) Table 54. Global Edaravone Sales Market Share by Application (2027-2032) Table 55. Global Edaravone Price by Application (2021-2026) & (US$/Unit) Table 56. Global Edaravone Price by Application (2027-2032) & (US$/Unit) Table 57. Mitsubishi Tanabe Pharma Company Information Table 58. Mitsubishi Tanabe Pharma Business Overview Table 59. Mitsubishi Tanabe Pharma Edaravone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Mitsubishi Tanabe Pharma Edaravone Product Portfolio Table 61. Mitsubishi Tanabe Pharma Recent Development Table 62. Piramal Healthcare Company Information Table 63. Piramal Healthcare Business Overview Table 64. Piramal Healthcare Edaravone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Piramal Healthcare Edaravone Product Portfolio Table 66. Piramal Healthcare Recent Development Table 67. Simcere Company Information Table 68. Simcere Business Overview Table 69. Simcere Edaravone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Simcere Edaravone Product Portfolio Table 71. Simcere Recent Development Table 72. Sun Pharmaceutical Industries Ltd. Company Information Table 73. Sun Pharmaceutical Industries Ltd. Business Overview Table 74. Sun Pharmaceutical Industries Ltd. Edaravone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sun Pharmaceutical Industries Ltd. Edaravone Product Portfolio Table 76. Sun Pharmaceutical Industries Ltd. Recent Development Table 77. Taj Pharmaceuticals Ltd. Company Information Table 78. Taj Pharmaceuticals Ltd. Business Overview Table 79. Taj Pharmaceuticals Ltd. Edaravone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Taj Pharmaceuticals Ltd. Edaravone Product Portfolio Table 81. Taj Pharmaceuticals Ltd. Recent Development Table 82. UCB India Ltd Company Information Table 83. UCB India Ltd Business Overview Table 84. UCB India Ltd Edaravone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. UCB India Ltd Edaravone Product Portfolio Table 86. UCB India Ltd Recent Development Table 87. Unichem Laboratories Ltd Company Information Table 88. Unichem Laboratories Ltd Business Overview Table 89. Unichem Laboratories Ltd Edaravone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Unichem Laboratories Ltd Edaravone Product Portfolio Table 91. Unichem Laboratories Ltd Recent Development Table 92. North America Edaravone Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Edaravone Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Edaravone Sales by Type (2021-2026) & (K Units) Table 95. North America Edaravone Sales by Type (2027-2032) & (K Units) Table 96. North America Edaravone Sales Price by Type (2021-2026) & (US$/Unit) Table 97. North America Edaravone Sales Price by Type (2027-2032) & (US$/Unit) Table 98. North America Edaravone Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Edaravone Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Edaravone Sales by Application (2021-2026) & (K Units) Table 101. North America Edaravone Sales by Application (2027-2032) & (K Units) Table 102. North America Edaravone Sales Price by Application (2021-2026) & (US$/Unit) Table 103. North America Edaravone Sales Price by Application (2027-2032) & (US$/Unit) Table 104. North America Edaravone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Edaravone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 106. North America Edaravone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 107. North America Edaravone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 108. North America Edaravone Sales by Country (2021-2026) & (K Units) Table 109. North America Edaravone Sales by Country (2027-2032) & (K Units) Table 110. North America Edaravone Sales Price by Country (2021-2026) & (US$/Unit) Table 111. North America Edaravone Sales Price by Country (2027-2032) & (US$/Unit) Table 112. United States Edaravone Revenue (2021-2032) & (US$ Million) Table 113. Canada Edaravone Revenue (2021-2032) & (US$ Million) Table 114. Mexico Edaravone Revenue (2021-2032) & (US$ Million) Table 115. Europe Edaravone Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Edaravone Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Edaravone Sales by Type (2021-2026) & (K Units) Table 118. Europe Edaravone Sales by Type (2027-2032) & (K Units) Table 119. Europe Edaravone Sales Price by Type (2021-2026) & (US$/Unit) Table 120. Europe Edaravone Sales Price by Type (2027-2032) & (US$/Unit) Table 121. Europe Edaravone Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Edaravone Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Edaravone Sales by Application (2021-2026) & (K Units) Table 124. Europe Edaravone Sales by Application (2027-2032) & (K Units) Table 125. Europe Edaravone Sales Price by Application (2021-2026) & (US$/Unit) Table 126. Europe Edaravone Sales Price by Application (2027-2032) & (US$/Unit) Table 127. Europe Edaravone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Edaravone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. Europe Edaravone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. Europe Edaravone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 131. Europe Edaravone Sales by Country (2021-2026) & (K Units) Table 132. Europe Edaravone Sales by Country (2027-2032) & (K Units) Table 133. Europe Edaravone Sales Price by Country (2021-2026) & (US$/Unit) Table 134. Europe Edaravone Sales Price by Country (2027-2032) & (US$/Unit) Table 135. Germany Edaravone Revenue (2021-2032) & (US$ Million) Table 136. France Edaravone Revenue (2021-2032) & (US$ Million) Table 137. U.K. Edaravone Revenue (2021-2032) & (US$ Million) Table 138. Italy Edaravone Revenue (2021-2032) & (US$ Million) Table 139. Russia Edaravone Revenue (2021-2032) & (US$ Million) Table 140. Spain Edaravone Revenue (2021-2032) & (US$ Million) Table 141. Netherlands Edaravone Revenue (2021-2032) & (US$ Million) Table 142. Switzerland Edaravone Revenue (2021-2032) & (US$ Million) Table 143. Sweden Edaravone Revenue (2021-2032) & (US$ Million) Table 144. Poland Edaravone Revenue (2021-2032) & (US$ Million) Table 145. China Edaravone Revenue by Type (2021-2026) & (US$ Million) Table 146. China Edaravone Revenue by Type (2027-2032) & (US$ Million) Table 147. China Edaravone Sales by Type (2021-2026) & (K Units) Table 148. China Edaravone Sales by Type (2027-2032) & (K Units) Table 149. China Edaravone Sales Price by Type (2021-2026) & (US$/Unit) Table 150. China Edaravone Sales Price by Type (2027-2032) & (US$/Unit) Table 151. China Edaravone Revenue by Application (2021-2026) & (US$ Million) Table 152. China Edaravone Revenue by Application (2027-2032) & (US$ Million) Table 153. China Edaravone Sales by Application (2021-2026) & (K Units) Table 154. China Edaravone Sales by Application (2027-2032) & (K Units) Table 155. China Edaravone Sales Price by Application (2021-2026) & (US$/Unit) Table 156. China Edaravone Sales Price by Application (2027-2032) & (US$/Unit) Table 157. Asia Edaravone Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Edaravone Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Edaravone Sales by Type (2021-2026) & (K Units) Table 160. Asia Edaravone Sales by Type (2027-2032) & (K Units) Table 161. Asia Edaravone Sales Price by Type (2021-2026) & (US$/Unit) Table 162. Asia Edaravone Sales Price by Type (2027-2032) & (US$/Unit) Table 163. Asia Edaravone Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Edaravone Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Edaravone Sales by Application (2021-2026) & (K Units) Table 166. Asia Edaravone Sales by Application (2027-2032) & (K Units) Table 167. Asia Edaravone Sales Price by Application (2021-2026) & (US$/Unit) Table 168. Asia Edaravone Sales Price by Application (2027-2032) & (US$/Unit) Table 169. Asia Edaravone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Edaravone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Edaravone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Edaravone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 173. Asia Edaravone Sales by Country (2021-2026) & (K Units) Table 174. Asia Edaravone Sales by Country (2027-2032) & (K Units) Table 175. Asia Edaravone Sales Price by Country (2021-2026) & (US$/Unit) Table 176. Asia Edaravone Sales Price by Country (2027-2032) & (US$/Unit) Table 177. Japan Edaravone Revenue (2021-2032) & (US$ Million) Table 178. South Korea Edaravone Revenue (2021-2032) & (US$ Million) Table 179. India Edaravone Revenue (2021-2032) & (US$ Million) Table 180. Australia Edaravone Revenue (2021-2032) & (US$ Million) Table 181. Taiwan Edaravone Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Edaravone Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Edaravone Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Edaravone Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Edaravone Sales by Type (2021-2026) & (K Units) Table 186. SAMEA Edaravone Sales by Type (2027-2032) & (K Units) Table 187. SAMEA Edaravone Sales Price by Type (2021-2026) & (US$/Unit) Table 188. SAMEA Edaravone Sales Price by Type (2027-2032) & (US$/Unit) Table 189. SAMEA Edaravone Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Edaravone Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Edaravone Sales by Application (2021-2026) & (K Units) Table 192. SAMEA Edaravone Sales by Application (2027-2032) & (K Units) Table 193. SAMEA Edaravone Sales Price by Application (2021-2026) & (US$/Unit) Table 194. SAMEA Edaravone Sales Price by Application (2027-2032) & (US$/Unit) Table 195. SAMEA Edaravone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Edaravone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Edaravone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Edaravone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 199. SAMEA Edaravone Sales by Country (2021-2026) & (K Units) Table 200. SAMEA Edaravone Sales by Country (2027-2032) & (K Units) Table 201. SAMEA Edaravone Sales Price by Country (2021-2026) & (US$/Unit) Table 202. SAMEA Edaravone Sales Price by Country (2027-2032) & (US$/Unit) Table 203. Brazil Edaravone Revenue (2021-2032) & (US$ Million) Table 204. Argentina Edaravone Revenue (2021-2032) & (US$ Million) Table 205. Chile Edaravone Revenue (2021-2032) & (US$ Million) Table 206. Colombia Edaravone Revenue (2021-2032) & (US$ Million) Table 207. Peru Edaravone Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Edaravone Revenue (2021-2032) & (US$ Million) Table 209. Israel Edaravone Revenue (2021-2032) & (US$ Million) Table 210. UAE Edaravone Revenue (2021-2032) & (US$ Million) Table 211. Turkey Edaravone Revenue (2021-2032) & (US$ Million) Table 212. Iran Edaravone Revenue (2021-2032) & (US$ Million) Table 213. Egypt Edaravone Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Edaravone Distributors List Table 217. Edaravone Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Edaravone Image Figure 2. Global Edaravone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Edaravone Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Edaravone Image Figure 5. Injection Edaravone Image Figure 6. Global Edaravone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Edaravone Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Edaravone Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Edaravone Revenue (2021-2032) & (US$ Million) Figure 13. Global Edaravone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Edaravone Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Edaravone Revenue Market Share by Region (2021-2032) Figure 16. Global Edaravone Sales (2021-2032) & (K Units) Figure 17. Global Edaravone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Edaravone Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Edaravone Sales YoY (2021-2032) & (K Units) Figure 20. Europe Edaravone Sales YoY (2021-2032) & (K Units) Figure 21. China Edaravone Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Edaravone Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Edaravone Sales YoY (2021-2032) & (K Units) Figure 24. Global Edaravone Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Edaravone Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Edaravone Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Edaravone Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Edaravone Revenue Market Share by Type (2021-2032) Figure 30. Global Edaravone Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Edaravone Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Edaravone Sales Market Share by Type (2021-2032) Figure 33. Global Edaravone Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Edaravone Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Edaravone Revenue Market Share by Application (2021-2032) Figure 36. Global Edaravone Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Edaravone Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Edaravone Sales Market Share by Application (2021-2032) Figure 39. North America Edaravone Revenue Share by Type (2021-2032) Figure 40. North America Edaravone Sales Share by Type (2021-2032) Figure 41. North America Edaravone Revenue Share by Application (2021-2032) Figure 42. North America Edaravone Sales Share by Application (2021-2032) Figure 43. North America Edaravone Revenue Share by Country (2021-2032) Figure 44. North America Edaravone Sales Share by Country (2021-2032) Figure 45. Europe Edaravone Revenue Share by Type (2021-2032) Figure 46. Europe Edaravone Sales Share by Type (2021-2032) Figure 47. Europe Edaravone Revenue Share by Application (2021-2032) Figure 48. Europe Edaravone Sales Share by Application (2021-2032) Figure 49. Europe Edaravone Revenue Share by Country (2021-2032) Figure 50. Europe Edaravone Sales Share by Country (2021-2032) Figure 51. China Edaravone Revenue Share by Type (2021-2032) Figure 52. China Edaravone Sales Share by Type (2021-2032) Figure 53. China Edaravone Revenue Share by Application (2021-2032) Figure 54. China Edaravone Sales Share by Application (2021-2032) Figure 55. Asia Edaravone Revenue Share by Type (2021-2032) Figure 56. Asia Edaravone Sales Share by Type (2021-2032) Figure 57. Asia Edaravone Revenue Share by Application (2021-2032) Figure 58. Asia Edaravone Sales Share by Application (2021-2032) Figure 59. Asia Edaravone Revenue Share by Country (2021-2032) Figure 60. Asia Edaravone Sales Share by Country (2021-2032) Figure 61. SAMEA Edaravone Revenue Share by Type (2021-2032) Figure 62. SAMEA Edaravone Sales Share by Type (2021-2032) Figure 63. SAMEA Edaravone Revenue Share by Application (2021-2032) Figure 64. SAMEA Edaravone Sales Share by Application (2021-2032) Figure 65. SAMEA Edaravone Revenue Share by Country (2021-2032) Figure 66. SAMEA Edaravone Sales Share by Country (2021-2032) Figure 67. Edaravone Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Edaravone Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Edaravone
  • Injection Edaravone
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Mitsubishi Tanabe Pharma
  • Piramal Healthcare
  • Simcere
  • Sun Pharmaceutical Industries Ltd.
  • Taj Pharmaceuticals Ltd.
  • UCB India Ltd
  • Unichem Laboratories Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Edaravone Market by Type
  3. 1.2.1 Global Edaravone Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Edaravone
  5. 1.2.3 Injection Edaravone
  6. 1.3 Edaravone Market by Application
  7. 1.3.1 Global Edaravone Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Edaravone Market Dynamics
  1. 2.1 Edaravone Industry Trends
  2. 2.2 Edaravone Industry Drivers
  3. 2.3 Edaravone Industry Opportunities and Challenges
  4. 2.4 Edaravone Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Edaravone Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Edaravone Revenue by Region
  3. 3.2.1 Global Edaravone Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Edaravone Revenue by Region (2021-2026)
  5. 3.2.3 Global Edaravone Revenue by Region (2027-2032)
  6. 3.2.4 Global Edaravone Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Edaravone Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Edaravone Sales by Region
  9. 3.4.1 Global Edaravone Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Edaravone Sales by Region (2021-2026)
  11. 3.4.3 Global Edaravone Sales by Region (2027-2032)
  12. 3.4.4 Global Edaravone Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Edaravone Revenue by Manufacturers
  2. 4.1.1 Global Edaravone Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Edaravone Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Edaravone Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Edaravone Sales by Manufacturers
  6. 4.2.1 Global Edaravone Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Edaravone Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Edaravone Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Edaravone Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Edaravone Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Edaravone Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Edaravone Manufacturers, Product Type & Application
  13. 4.7 Global Edaravone Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Edaravone Market CR5 and HHI
  16. 4.8.2 2025 Edaravone Tier 1, Tier 2, and Tier 3
5 Edaravone Market by Type
  1. 5.1 Global Edaravone Revenue by Type
  2. 5.1.1 Global Edaravone Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Edaravone Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Edaravone Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Edaravone Sales by Type
  6. 5.2.1 Global Edaravone Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Edaravone Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Edaravone Sales Market Share by Type (2021-2032)
  9. 5.3 Global Edaravone Price by Type
6 Edaravone Market by Application
  1. 6.1 Global Edaravone Revenue by Application
  2. 6.1.1 Global Edaravone Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Edaravone Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Edaravone Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Edaravone Sales by Application
  6. 6.2.1 Global Edaravone Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Edaravone Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Edaravone Sales Market Share by Application (2021-2032)
  9. 6.3 Global Edaravone Price by Application
7 Company Profiles
  1. 7.1 Mitsubishi Tanabe Pharma
  2. 7.1.1 Mitsubishi Tanabe Pharma Company Information
  3. 7.1.2 Mitsubishi Tanabe Pharma Business Overview
  4. 7.1.3 Mitsubishi Tanabe Pharma Edaravone Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Mitsubishi Tanabe Pharma Edaravone Product Portfolio
  6. 7.1.5 Mitsubishi Tanabe Pharma Recent Developments
  7. 7.2 Piramal Healthcare
  8. 7.2.1 Piramal Healthcare Company Information
  9. 7.2.2 Piramal Healthcare Business Overview
  10. 7.2.3 Piramal Healthcare Edaravone Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Piramal Healthcare Edaravone Product Portfolio
  12. 7.2.5 Piramal Healthcare Recent Developments
  13. 7.3 Simcere
  14. 7.3.1 Simcere Company Information
  15. 7.3.2 Simcere Business Overview
  16. 7.3.3 Simcere Edaravone Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Simcere Edaravone Product Portfolio
  18. 7.3.5 Simcere Recent Developments
  19. 7.4 Sun Pharmaceutical Industries Ltd.
  20. 7.4.1 Sun Pharmaceutical Industries Ltd. Company Information
  21. 7.4.2 Sun Pharmaceutical Industries Ltd. Business Overview
  22. 7.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sun Pharmaceutical Industries Ltd. Edaravone Product Portfolio
  24. 7.4.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  25. 7.5 Taj Pharmaceuticals Ltd.
  26. 7.5.1 Taj Pharmaceuticals Ltd. Company Information
  27. 7.5.2 Taj Pharmaceuticals Ltd. Business Overview
  28. 7.5.3 Taj Pharmaceuticals Ltd. Edaravone Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Taj Pharmaceuticals Ltd. Edaravone Product Portfolio
  30. 7.5.5 Taj Pharmaceuticals Ltd. Recent Developments
  31. 7.6 UCB India Ltd
  32. 7.6.1 UCB India Ltd Company Information
  33. 7.6.2 UCB India Ltd Business Overview
  34. 7.6.3 UCB India Ltd Edaravone Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 UCB India Ltd Edaravone Product Portfolio
  36. 7.6.5 UCB India Ltd Recent Developments
  37. 7.7 Unichem Laboratories Ltd
  38. 7.7.1 Unichem Laboratories Ltd Company Information
  39. 7.7.2 Unichem Laboratories Ltd Business Overview
  40. 7.7.3 Unichem Laboratories Ltd Edaravone Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Unichem Laboratories Ltd Edaravone Product Portfolio
  42. 7.7.5 Unichem Laboratories Ltd Recent Developments
8 North America
  1. 8.1 North America Edaravone Market Size by Type
  2. 8.1.1 North America Edaravone Revenue by Type (2021-2032)
  3. 8.1.2 North America Edaravone Sales by Type (2021-2032)
  4. 8.1.3 North America Edaravone Price by Type (2021-2032)
  5. 8.2 North America Edaravone Market Size by Application
  6. 8.2.1 North America Edaravone Revenue by Application (2021-2032)
  7. 8.2.2 North America Edaravone Sales by Application (2021-2032)
  8. 8.2.3 North America Edaravone Price by Application (2021-2032)
  9. 8.3 North America Edaravone Market Size by Country
  10. 8.3.1 North America Edaravone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Edaravone Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Edaravone Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Edaravone Market Size by Type
  2. 9.1.1 Europe Edaravone Revenue by Type (2021-2032)
  3. 9.1.2 Europe Edaravone Sales by Type (2021-2032)
  4. 9.1.3 Europe Edaravone Price by Type (2021-2032)
  5. 9.2 Europe Edaravone Market Size by Application
  6. 9.2.1 Europe Edaravone Revenue by Application (2021-2032)
  7. 9.2.2 Europe Edaravone Sales by Application (2021-2032)
  8. 9.2.3 Europe Edaravone Price by Application (2021-2032)
  9. 9.3 Europe Edaravone Market Size by Country
  10. 9.3.1 Europe Edaravone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Edaravone Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Edaravone Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Edaravone Market Size by Type
  2. 10.1.1 China Edaravone Revenue by Type (2021-2032)
  3. 10.1.2 China Edaravone Sales by Type (2021-2032)
  4. 10.1.3 China Edaravone Price by Type (2021-2032)
  5. 10.2 China Edaravone Market Size by Application
  6. 10.2.1 China Edaravone Revenue by Application (2021-2032)
  7. 10.2.2 China Edaravone Sales by Application (2021-2032)
  8. 10.2.3 China Edaravone Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Edaravone Market Size by Type
  2. 11.1.1 Asia Edaravone Revenue by Type (2021-2032)
  3. 11.1.2 Asia Edaravone Sales by Type (2021-2032)
  4. 11.1.3 Asia Edaravone Price by Type (2021-2032)
  5. 11.2 Asia Edaravone Market Size by Application
  6. 11.2.1 Asia Edaravone Revenue by Application (2021-2032)
  7. 11.2.2 Asia Edaravone Sales by Application (2021-2032)
  8. 11.2.3 Asia Edaravone Price by Application (2021-2032)
  9. 11.3 Asia Edaravone Market Size by Country
  10. 11.3.1 Asia Edaravone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Edaravone Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Edaravone Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Edaravone Market Size by Type
  2. 12.1.1 SAMEA Edaravone Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Edaravone Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Edaravone Price by Type (2021-2032)
  5. 12.2 SAMEA Edaravone Market Size by Application
  6. 12.2.1 SAMEA Edaravone Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Edaravone Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Edaravone Price by Application (2021-2032)
  9. 12.3 SAMEA Edaravone Market Size by Country
  10. 12.3.1 SAMEA Edaravone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Edaravone Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Edaravone Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Edaravone Value Chain Analysis
  2. 13.1.1 Edaravone Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Edaravone Production Mode & Process
  6. 13.2 Edaravone Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Edaravone Distributors
  9. 13.2.3 Edaravone Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst